On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Weekly Release  2003: Volume 7/ Issue 15 Article 4
Back to Table of Contents

Eurosurveillance, Volume 7, Issue 15, 10 April 2003

Citation style for this article: Editorial team. Index of SARS guidance produced by designated authorities in the European Union and elsewhere. Euro Surveill. 2003;7(15):pii=2202. Available online:

Index of SARS guidance produced by competent authorities in the European Union and elsewhere

Editorial team (, Eurosurveillance editorial office.

The Eurosurveillance editorial team has added a special page to the website which lists guidance and resources on Severe Acute Respiratory Syndrome (SARS) from government ministries of health and other competent authorities, in the European Union and elsewhere.

On 7 April, the Health and Consumer Protection Commissioner, David Byrne, made a European Commission statement on SARS at the European Parliament, the text of which can be viewed at

Previous Eurosurveillance Weekly articles on SARS are as follows:

  1. Horby P, Nicoll A. Severe Acute Respiratory Syndrome: international update. Eurosurveillance Weekly 2003; 7: 030403. (
  2. Eurosurveillance Weekly. Clinical descriptions of Severe Acute Respiratory Syndrome (SARS). Eurosurveillance Weekly 2003; 7: 030327. (
  3. Debenoist A-C, Boccia D. Severe Acute Respiratory Syndrome - update. Eurosurveillance Weekly 2003; 7: 030320. (
  4. Debenoist A-C, Boccia D. WHO initiates enhanced global surveillance in response to acute respiratory syndrome in China, Vietnam, and Hong Kong, special administrative region (SAR) of China. Eurosurveillance Weekly 2003; 7: 030313. (

back to top

Back to Table of Contents

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.